P16-INK4A antibody

Synonyms:ARF antibody, CDKN2A antibody, CDK4 inhibitor p16 INK4 antibody, CDK4 inhibitor p16INK4 antibody, CDK4I antibody, CDKN2 antibody, CDKN2A antibody, CMM2 antibody, INK4 antibody, INK4a antibody, MLM antibody, MTS 1 antibody, MTS1 antibody, Multiple tumor suppressor 1 antibody, p14 antibody, p14ARF antibody, P16 antibody, p16 INK4 antibody, p16 INK4a antibody, p16INK4 antibody, p16INK4a antibody, P19 antibody, TP16 antibody
Catalogue No.:FNab06064Reactivity:Human
Host:RabbitTested Application:ELISA, WB, IF, IP, IHC, FC
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
P16-INK4A antibody
Catalogue No.
FNab06064
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
cyclin-dependent kinase inhibitor 2A(melanoma, p16, inhibits CDK4)
Alternative Names
ARF antibody, CDKN2A antibody, CDK4 inhibitor p16 INK4 antibody, CDK4 inhibitor p16INK4 antibody, CDK4I antibody, CDKN2 antibody, CDKN2A antibody, CMM2 antibody, INK4 antibody, INK4a antibody, MLM antibody, MTS 1 antibody, MTS1 antibody, Multiple tumor suppressor 1 antibody, p14 antibody, p14ARF antibody, P16 antibody, p16 INK4 antibody, p16 INK4a antibody, p16INK4 antibody, p16INK4a antibody, P19 antibody, TP16 antibody
UniProt ID
P42771
Observed MW
16-18 kDa
Application
Tested Applications
ELISA, WB, IF, IP, IHC, FC
Recommended dilution
WB: 1:500-1:5000; IP: 1:500-1:5000; IHC: 1:50-1:500; IF: 1:20-1:200
Validated Images
HEK-293 cells were subjected to SDS PAGE followed by western blot with FNab06064(P16 antibody) at dilution of 1:1000
IP Result of anti-P16 (IP: FNab06064, 4ug; Detection: FNab06064 1:1000) with HEK-293 cells lysate 4500ug.
Immunohistochemistry of paraffin-embedded human tonsillitis tissue slide using FNab06064(P16-INK4A Antibody) at dilution of 1:200 heat mediated antigen retrieved with Tris-EDTA buffer(pH9).
Background
CDKN2A generates several transcript variants which differ in their first exons. At least three alternatively-spliced variants encoding distinct proteins have been reported, and two are related, named p16-INK4 and p14 respetively, sharing 50% identity. The third one is completely stuctually un-related, called p14(ARF) or p19(ARF). FNab06064 reacted with p16 specifically. P16 plays an important role in regulating the cell cycle, and mutations in p16 increase the risk of developing a variety of cancers, notably melanoma.